Second, the prevalence of autoantibodies against BP180 in healthy blood donors is approximately 0.52%, though potentially higher in older individuals, but still close to the prevalence of irBP among treated cancer patients,17, 19 highlighting the potential relevance of the PD‐1 mediated regulation of tissue inflammation for spontaneous BP. Here, COL17A1 is linked to cancer.